How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
50
RJF Quote, Financials, Valuation and Earnings
Last price:
$134.69
Seasonality move
:
1.49%
Day range:
$129.47 - $133.14
52-week range:
$104.24 - $174.32
Dividend yield:
1.45%
P/E ratio:
12.76x
P/S ratio:
2.10x
P/B ratio:
2.26x
Volume:
1.6M
Avg. volume:
1.9M
1-year change:
5.86%
Market cap:
$26.8B
Revenue:
$12.6B
EPS (TTM):
$10.25
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.9B | $9.6B | $10.9B | $11.5B | $12.6B | |
| Revenue Growth (YoY) | 3.18% | 22.07% | 12.68% | 5.69% | 10.21% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6B | $6.6B | $7.3B | $7.3B | $8.2B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $6B | $6.5B | $7.3B | $7.3B | $8.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.1B | $1.8B | $2B | $2.3B | $2.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $234M | $388M | $513M | $541M | $575M | |
| Net Income to Company | $818M | $1.4B | $1.5B | $1.7B | $2.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $818M | $1.4B | $1.5B | $1.7B | $2.1B | |
| Basic EPS (Cont. Ops) | $3.96 | $6.81 | $7.16 | $8.16 | $9.94 | |
| Diluted EPS (Cont. Ops) | $3.88 | $6.63 | $6.98 | $7.97 | $9.70 | |
| Weighted Average Basic Share | $206.4M | $205.7M | $209.9M | $211.8M | $207.1M | |
| Weighted Average Diluted Share | $210.3M | $211.2M | $215.3M | $216.9M | $212.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.2B | $1.9B | $2.3B | $3.7B | $4.7B | |
| Revenue (Reported) | $7.9B | $9.6B | $10.9B | $11.5B | $12.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.2B | $1.9B | $2.3B | $3.7B | $4.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.7B | $2.8B | $3B | $3.5B | |
| Revenue Growth (YoY) | 10.64% | 25.02% | 0.33% | 8.03% | 17.19% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6B | $1.9B | $1.7B | $1.9B | $2.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.6B | $1.9B | $1.7B | $1.9B | $2.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $399M | $558M | $652M | $630M | $749M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $87M | $112M | $143M | $132M | $149M | |
| Net Income to Company | $312M | $446M | $509M | $498M | $600M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $312M | $446M | $509M | $498M | $600M | |
| Basic EPS (Cont. Ops) | $1.52 | $2.16 | $2.36 | $2.38 | $2.94 | |
| Diluted EPS (Cont. Ops) | $1.48 | $2.10 | $2.30 | $2.32 | $2.86 | |
| Weighted Average Basic Share | $205.2M | $206.3M | $214.7M | $208.6M | $203.7M | |
| Weighted Average Diluted Share | $209.6M | $212.4M | $220.4M | $213.8M | $209.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $437M | $595M | $893M | $1.1B | $1.2B | |
| Revenue (Reported) | $2.2B | $2.7B | $2.8B | $3B | $3.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $437M | $595M | $893M | $1.1B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1B | $10.2B | $10.9B | $11.7B | $13.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.1B | $6.8B | $7.3B | $7.5B | $8.6B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $6.1B | $6.7B | $7.3B | $7.5B | $8.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.1B | $2B | $2.1B | $2.3B | $2.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $230M | $413M | $544M | $530M | $592M | |
| Net Income to Company | $862M | $1.5B | $1.6B | $1.7B | $2.2B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $862M | $1.5B | $1.6B | $1.7B | $2.2B | |
| Basic EPS (Cont. Ops) | $4.19 | $7.45 | $7.36 | $8.17 | $10.51 | |
| Diluted EPS (Cont. Ops) | $4.10 | $7.25 | $7.18 | $7.98 | $10.25 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.3B | $2.1B | $2.6B | $3.9B | $4.9B | |
| Revenue (Reported) | $8.1B | $10.2B | $10.9B | $11.7B | $13.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.3B | $2.1B | $2.6B | $3.9B | $4.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.7B | $2.8B | $3B | $3.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6B | $1.9B | $1.7B | $1.9B | $2.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.6B | $1.9B | $1.7B | $1.9B | $2.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $399M | $558M | $652M | $630M | $749M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $87M | $112M | $143M | $132M | $149M | |
| Net Income to Company | $312M | $446M | $509M | $498M | $600M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $312M | $446M | $509M | $498M | $600M | |
| Basic EPS (Cont. Ops) | $1.52 | $2.16 | $2.36 | $2.38 | $2.94 | |
| Diluted EPS (Cont. Ops) | $1.48 | $2.10 | $2.30 | $2.32 | $2.86 | |
| Weighted Average Basic Share | $205.2M | $206.3M | $214.7M | $208.6M | $203.7M | |
| Weighted Average Diluted Share | $209.6M | $212.4M | $220.4M | $213.8M | $209.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $437M | $595M | $893M | $1.1B | $1.2B | |
| Revenue (Reported) | $2.2B | $2.7B | $2.8B | $3B | $3.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $437M | $595M | $893M | $1.1B | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.4B | $7.2B | $6.2B | $9.3B | $11B | |
| Short Term Investments | $7.7B | $8.3B | $9.8B | $9.2B | $8.2B | |
| Accounts Receivable, Net | $2.4B | $2.8B | $2.9B | $2.5B | $2.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $123M | $127M | $173M | $209M | $220M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $17.4B | $19.7B | $20.9B | $23.1B | $24.1B | |
| Property Plant And Equipment | $856M | $945M | $983M | $1.1B | $1.2B | |
| Long-Term Investments | $8.5B | $9.3B | $10.2B | $9.6B | $8.8B | |
| Goodwill | $466M | $660M | $1.4B | $1.4B | $1.5B | |
| Other Intangibles | $134M | $222M | $509M | $470M | $435M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $47.5B | $61.9B | $81B | $78.4B | $83B | |
| Accounts Payable | $6.8B | $14B | $11.4B | $5.4B | $5.8B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $8.6B | $16B | $13.7B | $7.7B | $8.7B | |
| Long-Term Debt | $2.9B | $2.9B | $3.3B | $3.1B | $3.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $40.3B | $53.6B | $71.5B | $68.2B | $71.3B | |
| Common Stock | $2M | $2M | $122M | $81M | $81M | |
| Other Common Equity Adj | $11M | -$41M | -$982M | -$971M | -$502M | |
| Common Equity | $7.1B | $8.2B | $9.3B | $10.1B | $11.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $62M | $58M | -$26M | -$27M | -$6M | |
| Total Equity | $7.2B | $8.3B | $9.4B | $10.2B | $11.7B | |
| Total Liabilities and Equity | $47.5B | $61.9B | $81B | $78.4B | $83B | |
| Cash and Short Terms | $13B | $15.5B | $16B | $18.5B | $19.2B | |
| Total Debt | $2.9B | $2.9B | $3.3B | $3.1B | $3.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.4B | $8.2B | $6.2B | $10.2B | $10B | |
| Short Term Investments | $8B | $8.5B | $9.8B | $9.2B | $7.7B | |
| Accounts Receivable, Net | $2.3B | $2.7B | $2.6B | $2.4B | $2.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $134M | $186M | $257M | $245M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $17B | $21.2B | $20.2B | $23.8B | $22.3B | |
| Property Plant And Equipment | $534M | $930M | $970M | $1.1B | $1.2B | |
| Long-Term Investments | $9.2B | $9.6B | $11.2B | $9.6B | $8.3B | |
| Goodwill | $606M | $660M | -- | -- | -- | |
| Other Intangibles | $228M | $214M | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $53.7B | $68.5B | $77B | $80.1B | $82.3B | |
| Accounts Payable | $11.9B | $19.2B | $7.7B | $5.8B | $5.7B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $13.9B | $21B | $9.6B | $8.2B | $8.5B | |
| Long-Term Debt | $2.9B | $2.9B | $3.2B | $3.1B | $3.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $46.2B | $59.8B | $67.2B | $69.3B | $70.4B | |
| Common Stock | $2M | $2M | $122M | $81M | $82M | |
| Other Common Equity Adj | $17M | -$87M | -$891M | -$693M | -$655M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $75M | $52M | -$26M | -$9M | $6M | |
| Total Equity | $7.4B | $8.7B | $9.8B | $10.8B | $11.9B | |
| Total Liabilities and Equity | $53.7B | $68.5B | $77B | $80.1B | $82.3B | |
| Cash and Short Terms | $13.4B | $16.8B | $16B | $19.4B | $17.8B | |
| Total Debt | $2.9B | $2.9B | $3.2B | $3.1B | $3.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $818M | $1.4B | $1.5B | $1.7B | $2.1B | |
| Depreciation & Amoritzation | $119M | $134M | $145M | $165M | $179M | |
| Stock-Based Compensation | $120M | $132M | $192M | $237M | $254M | |
| Change in Accounts Receivable | $127M | -$420M | -$203M | $257M | -$362M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $4.1B | $6.6B | $72M | -$3.5B | $2.2B | |
| Capital Expenditures | $124M | $74M | $91M | $173M | $205M | |
| Cash Acquisitions | -$5M | -$266M | $1.5B | -- | -- | |
| Cash From Investing | -$5B | -$5.1B | -$7.2B | -$274M | -$968M | |
| Dividends Paid (Ex Special Dividend) | -$205M | -$218M | -$277M | -$355M | -$383M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $737M | $1B | $3.2B | $1.3B | |
| Long-Term Debt Repaid | -$855M | -$875M | -$967M | -$3.4B | -$1.4B | |
| Repurchase of Common Stock | -$291M | -$150M | -$216M | -$902M | -$984M | |
| Other Financing Activities | -$1M | -$9M | -$7M | -$2M | -$2M | |
| Cash From Financing | $4.6B | $5.2B | $5.9B | $1.4B | $438M | |
| Beginning Cash (CF) | $6B | $9.6B | $16.4B | $14.7B | $12.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.7B | $6.7B | -$1.2B | -$2.4B | $1.6B | |
| Ending Cash (CF) | $9.6B | $16.4B | $14.7B | $12.5B | $14.3B | |
| Levered Free Cash Flow | $3.9B | $6.6B | -$19M | -$3.7B | $2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $312M | $446M | $509M | $498M | $600M | |
| Depreciation & Amoritzation | $32M | $35M | $40M | $42M | $47M | |
| Stock-Based Compensation | $43M | $65M | $81M | $90M | $93M | |
| Change in Accounts Receivable | $254M | $197M | $477M | $304M | $331M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.9B | -$2.3B | -$3.1B | $543M | $830M | |
| Capital Expenditures | $25M | $19M | $27M | $50M | $41M | |
| Cash Acquisitions | -$218M | -- | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$1.6B | -$666M | -$176M | -$937M | |
| Dividends Paid (Ex Special Dividend) | -$55M | -$60M | -$81M | -$97M | -$105M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $850M | $650M | $750M | $450M | |
| Long-Term Debt Repaid | -$26M | -$851M | -$791M | -$750M | -$450M | |
| Repurchase of Common Stock | -$35M | -$51M | -$189M | -$199M | -$185M | |
| Other Financing Activities | -- | -$5M | -$1M | -$1M | -$7M | |
| Cash From Financing | $891M | $1.5B | $221M | $907M | -$447M | |
| Beginning Cash (CF) | $9.6B | $16.4B | $14.7B | $12.5B | $14.3B | |
| Foreign Exchange Rate Adjustment | $73M | $3M | $215M | $115M | -$214M | |
| Additions / Reductions | $1.7B | -$2.3B | -$3.6B | $1.3B | -$554M | |
| Ending Cash (CF) | $11.4B | $14.1B | $11.3B | $13.9B | $13.6B | |
| Levered Free Cash Flow | $1.9B | -$2.3B | -$3.2B | $493M | $789M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $862M | $1.5B | $1.6B | $1.7B | $2.2B | |
| Depreciation & Amoritzation | $121M | $137M | $150M | $167M | $184M | |
| Stock-Based Compensation | $120M | $154M | $208M | $246M | $257M | |
| Change in Accounts Receivable | $193M | -$477M | $77M | $84M | -$335M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.4B | $2.4B | -$777M | $165M | $2.4B | |
| Capital Expenditures | $113M | $68M | $99M | $196M | $196M | |
| Cash Acquisitions | -$223M | -$48M | $1.5B | -- | -- | |
| Cash From Investing | -$5.6B | -$5.6B | -$6.3B | $216M | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$209M | -$223M | -$298M | -$371M | -$391M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.6B | $825M | $3.3B | $1B | |
| Long-Term Debt Repaid | -$30M | -$1.7B | -$907M | -$3.4B | -$1.1B | |
| Repurchase of Common Stock | -$307M | -$166M | -$354M | -$912M | -$970M | |
| Other Financing Activities | -- | -- | -$3M | -$2M | -$8M | |
| Cash From Financing | $4.8B | $5.8B | $4.6B | $2.1B | -$916M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.7B | $2.7B | -$2.4B | $2.5B | -$203M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $5.3B | $2.4B | -$876M | -$31M | $2.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $312M | $446M | $509M | $498M | $600M | |
| Depreciation & Amoritzation | $32M | $35M | $40M | $42M | $47M | |
| Stock-Based Compensation | $43M | $65M | $81M | $90M | $93M | |
| Change in Accounts Receivable | $254M | $197M | $477M | $304M | $331M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.9B | -$2.3B | -$3.1B | $543M | $830M | |
| Capital Expenditures | $25M | $19M | $27M | $50M | $41M | |
| Cash Acquisitions | -$218M | -- | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$1.6B | -$666M | -$176M | -$937M | |
| Dividends Paid (Ex Special Dividend) | -$55M | -$60M | -$81M | -$97M | -$105M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $850M | $650M | $750M | $450M | |
| Long-Term Debt Repaid | -$26M | -$851M | -$791M | -$750M | -$450M | |
| Repurchase of Common Stock | -$35M | -$51M | -$189M | -$199M | -$185M | |
| Other Financing Activities | -- | -$5M | -$1M | -$1M | -$7M | |
| Cash From Financing | $891M | $1.5B | $221M | $907M | -$447M | |
| Beginning Cash (CF) | $9.6B | $16.4B | $14.7B | $12.5B | $14.3B | |
| Foreign Exchange Rate Adjustment | $73M | $3M | $215M | $115M | -$214M | |
| Additions / Reductions | $1.7B | -$2.3B | -$3.6B | $1.3B | -$554M | |
| Ending Cash (CF) | $11.4B | $14.1B | $11.3B | $13.9B | $13.6B | |
| Levered Free Cash Flow | $1.9B | -$2.3B | -$3.2B | $493M | $789M | |
Get RJF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RJF
Sector
P/E ratio
12.76x
10.71x
PEG ratio
0.45x
0.37x
P/B ratio
2.26x
1.00x
Price / LTM sales
2.10x
2.36x
Growth Metrics
RJF
Sector
Revenue growth
17.19%
6.77%
Earnings growth
23.28%
7.04%
Revenue (5-year growth)
10.58%
5.17%
Earnings forecast
$2.44
$0.57
Profitability
RJF
Sector
Profitability FY 2025
--
$155.9M
Return on invested capital
15.01%
5.51%
Return on assets
2.66%
1%
Return on equity
19.19%
9.5%
Earnings Date
Last Earnings Date
Jan
29
Next Earnings Date
Apr
23
Estimated Next Earnings Date
Apr
30
Balance Sheet
RJF
Sector
Total cash
$17.8B
$471.6M
Short term investments
$8.2B
$241.7M
Total assets
$83B
$4.2B
Long term debt
$3.1B
$333.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
